Search research articles
Contact Us
Filters
Showing results (81-90 of 93) with videos related to
Page
of 10
Sort By:
Cytotherapy
|
February 27, 2022
Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trials
Mark D Stewart, Bruce McCall, Marcelo Pasquini, et al.
Infection and Immunity
|
November 30, 2016
The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines
Diego A Espinosa, Joel Vega-Rodriguez, Yevel Flores-Garcia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2017
Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement
Edward S Kim, Suanna S Bruinooge, Samantha Roberts, et al.
The Oncologist
|
March 11, 2022
Homologous Recombination Deficiency: Concepts, Definitions, and Assays
Mark D Stewart, Diana Merino Vega, Rebecca C Arend, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 3, 2020
Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology Study
Albrecht Stenzinger, Volker Endris, Jan Budczies, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 27, 2019
Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical Artifacts
Daniel Kazdal, Volker Endris, Michael Allgäuer, et al.
Plos One
|
February 3, 2023
Real-world performance of SARS-Cov-2 serology tests in the United States, 2020
Carla V Rodriguez-Watson, Anthony M Louder, Carly Kabelac, et al.
Journal for Immunotherapy of Cancer
|
March 29, 2020
Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project
Diana M Merino, Lisa M McShane, David Fabrizio, et al.
Plos One
|
February 10, 2023
Real-world utilization of SARS-CoV-2 serological testing in RNA positive patients across the United States
Carla V Rodriguez-Watson, Natalie E Sheils, Anthony M Louder, et al.
JCO Precision Oncology
|
August 11, 2022
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
Diana Merino Vega, Katherine K Nishimura, Névine Zariffa, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 93) with videos related to
Sort By:
Page
of 10
Cytotherapy
|
February 27, 2022
Need for aligning the definition and reporting of cytokine release syndrome (CRS) in immuno-oncology clinical trials
Mark D Stewart, Bruce McCall, Marcelo Pasquini, et al.
Infection and Immunity
|
November 30, 2016
The Plasmodium falciparum Cell-Traversal Protein for Ookinetes and Sporozoites as a Candidate for Preerythrocytic and Transmission-Blocking Vaccines
Diego A Espinosa, Joel Vega-Rodriguez, Yevel Flores-Garcia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2017
Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement
Edward S Kim, Suanna S Bruinooge, Samantha Roberts, et al.
The Oncologist
|
March 11, 2022
Homologous Recombination Deficiency: Concepts, Definitions, and Assays
Mark D Stewart, Diana Merino Vega, Rebecca C Arend, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 3, 2020
Harmonization and Standardization of Panel-Based Tumor Mutational Burden Measurement: Real-World Results and Recommendations of the Quality in Pathology Study
Albrecht Stenzinger, Volker Endris, Jan Budczies, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 27, 2019
Spatial and Temporal Heterogeneity of Panel-Based Tumor Mutational Burden in Pulmonary Adenocarcinoma: Separating Biology From Technical Artifacts
Daniel Kazdal, Volker Endris, Michael Allgäuer, et al.
Plos One
|
February 3, 2023
Real-world performance of SARS-Cov-2 serology tests in the United States, 2020
Carla V Rodriguez-Watson, Anthony M Louder, Carly Kabelac, et al.
Journal for Immunotherapy of Cancer
|
March 29, 2020
Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project
Diana M Merino, Lisa M McShane, David Fabrizio, et al.
Plos One
|
February 10, 2023
Real-world utilization of SARS-CoV-2 serological testing in RNA positive patients across the United States
Carla V Rodriguez-Watson, Natalie E Sheils, Anthony M Louder, et al.
JCO Precision Oncology
|
August 11, 2022
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
Diana Merino Vega, Katherine K Nishimura, Névine Zariffa, et al.
Page
of 10